Product Information
The NGAL antibody is a specific antibody that targets the epidermal growth factor (EGF) and tumor necrosis factor-alpha (TNF-α). It falls under the category of Life Sciences and Monoclonal Antibodies. This antibody has been shown to have neutralizing effects on autoantibodies and growth factors such as collagen, transforming growth factor-beta (TGF-beta), and fibronectin. By targeting these factors, the NGAL antibody can help regulate cell signaling pathways and inhibit abnormal cell growth. Additionally, this antibody has been found to be effective in blocking the activation of chemokines, which play a crucial role in inflammation and immune response. With its high specificity and neutralizing properties, the NGAL antibody holds great potential for therapeutic applications in various fields of research and medicine.